We’ve made significant progress in developing better treatments for multiple sclerosis over the last two decades. Yet the medical community still struggles to diagnose the neurological condition, let alone intervene or study it in its earliest stages, before damage has been done. What we need is a simple test that can definitively tell a patient if they have MS — or are on the road to developing it.
It’s still a distant scenario, but a discovery from researchers at the University of California at San Francisco brings it a bit closer to reality.
The UCSF team has identified a distinct collection ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
